Rufinamide Suspension
Product Images NDC 59651-563

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Rufinamide (NDC 59651-563). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig1 (Rufinamide Fig 1)

Fig1 (Rufinamide Fig 1)
FDA Label Image

Fig10 (Rufinamide Fig 10)

Fig10 (Rufinamide Fig 10)
FDA Label Image

Fig11 (Rufinamide Fig 11)

Fig11 (Rufinamide Fig 11)
FDA Label Image

Figure 12 (Rufinamide Fig 12)

Figure 12 (Rufinamide Fig 12)
This is a description of Rufinamide, an oral suspension medication that contains 40 mg of Rufinamide USP per mL. It is only to be administered orally and comes in a 460 mL bottle. The medication guide should be provided to each patient alongside the medication. It should be stored at a temperature of 20° to 25°C (68° to 77°F) and discarded within 90 days of opening. This medication is distributed by Aurobindo Pharma USA, Inc. and manufactured in India. There is also a reference to a code: AP/DRUGS/04/2016.*
FDA Label Image

Figure 13 (Rufinamide Fig 13)

Figure 13 (Rufinamide Fig 13)
This is a description of Rufinamide, an oral suspension medication which is supplied with two 20mL syringes for oral administration only. The medication must be shaken well before use and instructions for administration can be found in the enclosed prescribing information. This medication contains Rufinamide USP 40mg per mL of oral suspension. It is distributed by Aurobindo Pharma USA and made in India. Customers are encouraged to check the website aurobindousa.com for medication guides and it should only be used under prescription. It has to be stored at 20° to 25°C and discarded within 90 days after opening.*
FDA Label Image

Fig2 (Rufinamide Fig 2)

Fig2 (Rufinamide Fig 2)
FDA Label Image

Fig3 (Rufinamide Fig 3)

Fig3 (Rufinamide Fig 3)
FDA Label Image

Fig4 (Rufinamide Fig 4)

Fig4 (Rufinamide Fig 4)
FDA Label Image

Fig5 (Rufinamide Fig 5)

Fig5 (Rufinamide Fig 5)
FDA Label Image

Fig6 (Rufinamide Fig 6)

Fig6 (Rufinamide Fig 6)
FDA Label Image

Fig7 (Rufinamide Fig 7)

Fig7 (Rufinamide Fig 7)
FDA Label Image

Fig8 (Rufinamide Fig 8)

Fig8 (Rufinamide Fig 8)
FDA Label Image

Fig9 (Rufinamide Fig 9)

Fig9 (Rufinamide Fig 9)
FDA Label Image

Structure (Rufinamide Str)

Structure (Rufinamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.